Ethical considerations in CYP2D6 genotype testing for codeine-prescribed breastfeeding mothers.
Clin Pharmacol Ther
; 88(6): 760-2, 2010 Dec.
Article
em En
| MEDLINE
| ID: mdl-21081947
ABSTRACT
In this issue, Madadi et al. report on interviews with codeine-prescribed breastfeeding mothers concerning preferences and attitudes toward receiving their CYP2D6 genotype and overall study findings. We address three sets of ethics questions raised by this article. Should genetic information be disclosed to research participants in genetic research? What should clinicians take into account when considering this genetic test in managing infant opioid toxicity risk? What conditions support or hinder the integration of genetic information into patient care?
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Aleitamento Materno
/
Testes Genéticos
/
Codeína
/
Citocromo P-450 CYP2D6
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article